Awesome post. This reminds me of an article from 2007 I read on the weekend. It's 50 odd pages but well worth the read if you have the time. Very helpful if anyone wants more information on:
- method of action and the science behind why pentosan can do what it does
- the potential pipeline of indications, in case you were worried the company is a one trick pony - ie. OA or bust
- context behind why PPS has yet to be commercialised beyond elmiron and animal use
- PAR's links to Biopharm/Arthropharm (the maker of Cartrophen Vet) through Prof Peter Ghosh
http://www.naturalmedicine.net.nz/wp-content/uploads/2013/10/1-Polisulfate-to-PDF1.pdf
Awesome post. This reminds me of an article from 2007 I read on...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $74.06K | 320.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 102830 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 703 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |